z-logo
open-access-imgOpen Access
5-Fluorouracil-Induced Chest Pain and ST-Segment Elevation
Author(s) -
Allison Dupont,
Mauricio G. Cohen
Publication year - 2008
Publication title -
clinical medicine cardiology
Language(s) - English
Resource type - Journals
ISSN - 1178-1165
DOI - 10.4137/cmc.s297
Subject(s) - medicine , cardiotoxicity , chest pain , coronary vasospasm , coronary artery disease , adverse effect , vasospasm , cardiology , fluorouracil , st segment , ischemia , st elevation , chemotherapy , electrocardiography , angina , myocardial infarction , subarachnoid hemorrhage
5-Fluorouracil (5-FU) is a chemotherapeutic agent commonly used to treat various malignancies. Cardiotoxicity is a rare adverse effect in patients being treated with 5-FU, but it can be severe and even fatal. The mechanism of myocardial ischemia caused by 5-FU is not known but several hypotheses exist, of which coronary vasospasm is the most widely accepted. Importantly, patients with preexisting coronary artery disease have been shown to be at increased risk of developing myocardial ischemia secondary to 5-FU. We present a case of 5-FU-induced chest pain and ST segment elevation in a patient with pre-existing coronary artery disease. The aim of this article is to provide a brief review of the available literature surrounding the topic of 5-FU cardiotoxicity and to heighten the readers' awareness of the potential adverse cardiac effects of this agent.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom